Nephros Inc.
3960 Broadway
New York
New York
10032
United States
Tel: 212-781-5113
Fax: 212-781-5166
Website: http://www.nephros.com/
Email: info@nephros.com
212 articles about Nephros Inc.
-
Nephros Inc. Reports 2010 Fourth Quarter and Full Year Financial Results
3/30/2011
-
Nephros Inc. Announces Split Adjusted Trade Date
3/16/2011
-
Nephros Inc. Announces Completion of Reverse Stock Split
3/14/2011
-
Nephros Inc. Announces Completion of $3.2 Million Financing Through Rights Offering and Private Placement Transactions
3/11/2011
-
Nephros Inc. Announces $3.2 Million Financing Through Completion of Rights Offering and Private Placement Transactions
3/7/2011
-
Nephros Inc. Extends Rights Offering
3/1/2011
-
Nephros Inc. Rights Offering Registration Statement Declared Effective
2/1/2011
-
Nephros Inc. Reports 2010 Third Quarter Financial Results
11/15/2010
-
Nephros Inc. Reports 2010 Second Quarter Financial Results
8/17/2010
-
Nephros Inc. Receives Formal Response from FDA for 510(k) Application for Hemodiafiltration System; FDA Rejects Application
7/8/2010
-
Nephros Inc. Reports 2010 First Quarter Financial Results
5/14/2010
-
Nephros Inc. Signs Development Agreement with Steris Corporation
3/24/2010
-
Nephros Inc. Signs Development Agreement with Steris Corporation
3/23/2010
-
Nephros Inc. Signs Canadian Distribution Agreement with BHC Medical
2/26/2010
-
Nephros Inc. Reports 2009 Second Quarter Financial Results
8/17/2009
-
Nephros Inc. Completes $1.25 Million Private Placement
7/31/2009
-
Nephros Inc. Reports 2008 Fourth Quarter and Full Year Financial Results
3/31/2009
-
Nephros Inc. Provides Update on 510k Applications
2/25/2009
-
Nephros Inc. Common Stock Now Quoted in Pink Sheets
1/27/2009
-
Nephros Inc. Receives Notice of Intention to Delist from AMEX
1/16/2009